Clinical trial
Preoperative Treatment of Patients With High Risk Thymoma
NCT00387868 · Valley Health System, Other · Completed
Key facts
| NCT number | NCT00387868 |
|---|---|
| Title | Preoperative Treatment of Patients With High Risk Thymoma |
| Official title | Phase II Study of Trimodality Therapy for Patients With Thymoma or Thymic Carcinoma at Significant Risk for Recurrence |
| Lead sponsor | Valley Health System, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thymoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin and etoposide, Surgical Resection, Concurrent Radiotherapy |
| Enrollment | 21 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2014 |
| Completion | Nov 1, 2014 |
| First posted | Oct 13, 2006 |
| Last update posted | Dec 9, 2014 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: